CRISPRIL-13Rα2CAR T:I

Xuetao Li1, Xiaoyun Shang2, Jiangang Liu3

  • 1Department of Neurosurgery, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.

Nature communications
|January 6, 2026
PubMed
概括

这项研究表明,全基性通用CAR-T细胞疗法 (MT026) 对复发性质母细胞瘤是安全有效的. 早期的结果表明,在治疗选择有限的患者中,瘤反应显著.